PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $199,320 | -26.5% | 11,000 | +7.8% | 0.52% | +194.4% |
| Q1 2023 | $271,320 | +37.6% | 10,200 | 0.0% | 0.18% | +16.3% |
| Q4 2022 | $197,166 | -7.4% | 10,200 | 0.0% | 0.15% | +41.7% |
| Q3 2022 | $213,000 | +159.8% | 10,200 | 0.0% | 0.11% | +129.8% |
| Q2 2022 | $82,000 | +13.9% | 10,200 | 0.0% | 0.05% | +30.6% |
| Q1 2022 | $72,000 | -47.8% | 10,200 | 0.0% | 0.04% | -61.7% |
| Q4 2021 | $138,000 | – | 10,200 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |